CureVac
Yuliia Obolonyk is a Quality Transfer Manager at CureVac, a position held since August 2022. Previously, Yuliia served as the Head of the transfer group for contracted products at Arterium from July 2014 to May 2022, leading a team in the transfer of pharmaceutical production technologies and analytical methods, while ensuring correct production practices and managing project plans and reporting. Yuliia also held roles as a Senior Analytical Chemist and R&D Analytical Chemist at Arterium, focusing on the pharmaceutical development of new drug products and managing analytical chemists. Yuliia holds a Master's degree and a Bachelor's degree in Chemistry from V. N. Karazin Kharkiv National University.
CureVac
8 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.